1 – 13 of 13
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Registry-based randomised clinical trials : a remedy for evidence-based diabetes care?
(
- Contribution to journal › Scientific review
- 2021
-
Mark
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease : A double-blind, randomized, placebo-controlled study
(
- Contribution to journal › Article
- 2017
-
Mark
Genotype-based recall to study metabolic effects of genetic variation : a pilot study of PPARG Pro12Ala carriers
(
- Contribution to journal › Article
- 2012
-
Mark
Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.
(
- Contribution to journal › Article
- 2007
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
-
Mark
Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.
(
- Contribution to journal › Article
- 2003
-
Mark
Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease: A prospective, randomized, double-blind, placebo-controlled study.
(
- Contribution to journal › Article
-
Mark
Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).
(
- Contribution to journal › Article
-
Mark
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).
(
- Contribution to journal › Article
- 2002
-
Mark
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
(
- Contribution to journal › Article
- 2001
-
Mark
Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults - A nationwide study
(
- Contribution to journal › Article
- 1999
-
Mark
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment : A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes
(
- Contribution to journal › Article